Satraplatin: A new treatment option for patients with hormone refractory prostate cancer.

被引：0
|
作者：
Nathan, FE
Sternberg, C
Sartor, O
Petrylak, D
Witjes, F
Wosikowski, K
Petrone, ME
Rozencweig, M
机构：
[1] GPC Biotech Inc, Princeton, NJ USA
[2] San Camillo Hosp, Rome, Italy
[3] Forlanini Hosp, Rome, Italy
[4] LSU, Sch Med, New Orleans, LA USA
[5] Columbia Presbyterian Med Ctr, New York, NY 10032 USA
[6] Acad Ziekenhuis, Nijmegen, Netherlands
[7] GPC Biotech AG, Munich, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：453S / 453S
页数：1
相关论文
共 50 条
  • [21] Phase II protocol with docetaxel plus prednisone in patients with hormone refractory prostate cancer.
    Silva, E
    Da Silava, FMC
    Da Silava, FEC
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 449S - 449S
  • [22] A combination docetaxel-capecitabine in patients (pts) with hormone refractory advanced prostate cancer.
    Ferrero, J
    Berdah, JF
    Chamorey, E
    Oudard, S
    Dides, S
    Lesbats, G
    Cavaglione, G
    Nouyrigat, P
    Foa, C
    Guillet, P
    Kaphan, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 412S - 412S
  • [23] Biomarker development trial of satraplatin in patients with metastatic castrate-resistant prostate cancer.
    Liaw, Bobby Chi-Hung
    Seng, Sonia Maria
    Galsky, Matt D.
    Tsao, Che-Kai
    Febbo, Phillip G.
    Oh, William K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [24] Systemic treatment of hormone refractory prostate cancer
    H. Rübben
    A. Bex
    T. Otto
    World Journal of Urology, 2001, 19 : 99 - 110
  • [25] TREATMENT IN METASTATIC PROSTATE CANCER WITH HORMONE REFRACTORY
    Vitello, S.
    Vacirca, F.
    Triglia, E.
    Giarratano, G.
    EJC SUPPLEMENTS, 2008, 6 (14): : 126 - 126
  • [26] Systemic treatment of hormone refractory prostate cancer
    Rübben, H
    Bex, A
    Otto, T
    WORLD JOURNAL OF UROLOGY, 2001, 19 (02) : 99 - 110
  • [27] Advances in the treatment of hormone refractory prostate cancer
    Petrylak, Daniel P.
    CANCER INVESTIGATION, 2007, 25 : 19 - 19
  • [28] Satraplatin in hormone-refractory prostate cancer and other tumour types - Pharmacological properties and clinical evaluation
    McKeage, Mark J.
    DRUGS, 2007, 67 (06) : 859 - 869
  • [29] New approaches in hormone refractory prostate cancer
    Sonpavde, G
    Hutson, TE
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (02): : 196 - 201
  • [30] New hope for patients with metastatic hormone-refractory prostate cancer
    de Wit, Ronald
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (15) : 817 - 823
12345